openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Avis Budget Group, Inc. (NASDAQ: CAR) over possible Wrongdoing

An investigation on behalf of current long term investors in Avis Budget Group, Inc. (NASDAQ: CAR) shares.

An investigation on behalf of current long term investors in Avis Budget Group, Inc. (NASDAQ: CAR) shares.

An investigation was announced on behalf of current long-term investors in shares of Avis Budget Group, Inc. (NASDAQ: CAR) concerning potential breaches of fiduciary duties by certain directors of Avis Budget Group, Inc.

Investors who are current long term investors in Avis Budget Group, Inc. (NASDAQ: CAR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: CAR stocks follows a lawsuit filed against Avis Budget Group, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CAR stocks, concerns whether certain Avis Budget Group, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Avis Budget Group, Inc. crafted and implemented a plan to significantly accelerate its fleet rotation in the fourth quarter of 2024, that the foregoing acceleration shortened the useful life of the majority of the Company's vehicles in the Americas segment, thereby reducing their recoverable value, that as a result, Avis Budget Group, Inc. would be forced to recognize billions of dollars in impairment charges and incur substantial losses, that all the foregoing was likely to, and did, have a significant negative impact on the Company's financial results, that accordingly, Avis Budget's financial and/or business prospects were overstated, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Avis Budget Group, Inc. (NASDAQ: CAR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Avis Budget Group, Inc. (NASDAQ: CAR) over possible Wrongdoing here

News-ID: 4144711 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG)
Lawsuit filed for Investors who lost money with shares of Neogen Corporation (NA …
An investor, who purchased shares of Neogen Corporation (NASDAQ: NEOG), filed a lawsuit over alleged violations of Federal Securities Laws by Neogen Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2025. NASDAQ: NEOG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
NYSE: ANRO Lawsuit Alert: Investors who lost money with shares of Alto Neuroscience, Inc. (NYSE: ANRO) should contact the Shareholders Foundation
NYSE: ANRO Lawsuit Alert: Investors who lost money with shares of Alto Neuroscie …
An investor, who purchased shares of Alto Neuroscience, Inc. (NYSE: ANRO), filed a lawsuit over alleged violations of Federal Securities Laws by Alto Neuroscience, Inc. in connection with certain allegedly false and misleading statements made between February 2, 2024 and October 22, 2024 and in connection with the Company's initial public offering conducted on or about February 2, 2024 (the "IPO" or "Offering"). Investors who purchased shares of Alto Neuroscience, Inc.
Investigation announced for Investors who hold shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) over potential Wrongdoing
Investigation announced for Investors who hold shares of Zenas BioPharma, Inc. ( …
An investigation was announced for long-term investors in shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) concerning potential breaches of fiduciary duties by certain directors of Zenas BioPharma, Inc. Investors who are current long term investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in NASDAQ: ZBIO stocks
Lawsuit filed for Investors who lost money with shares of RxSight, Inc. (NASDAQ: RXST)
Lawsuit filed for Investors who lost money with shares of RxSight, Inc. (NASDAQ: …
An investor, who purchased shares of RxSight, Inc. (NASDAQ: RXST), filed a lawsuit over alleged violations of Federal Securities Laws by RxSight, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of RxSight, Inc. (NASDAQ: RXST) have certain options and for certain investors are short and strict deadlines running. Deadline: September 22, 2025. NASDAQ: RXST investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Avis

"Diaetolin Erfahrungen" - Stiftung Warentest [Diaetolin Kaufen] Avis?
𝐃𝐢𝐚𝐞𝐭𝐨𝐥𝐢𝐧 𝐢𝐬 𝐚 𝐰𝐞𝐢𝐠𝐡𝐭 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 that is both healthy as well as reliable, and it makes the promise that it may assist individuals reduce weight instantly and also get slim quickly. 👉 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐍𝐚𝐦𝐞:- 𝐃𝐢𝐚𝐞𝐭𝐨𝐥𝐢𝐧 👉 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬:- 𝐁𝐇𝐁 , 𝐆𝐚𝐫𝐜𝐢𝐧𝐢𝐚 𝐂𝐚𝐦𝐛𝐨𝐠𝐢𝐚 👉 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:- 𝐖𝐞𝐢𝐠𝐡𝐭 𝐋𝐨𝐬𝐬 👉 𝐑𝐚𝐭𝐢𝐧𝐠:- ⭐⭐⭐⭐⭐ 👉 𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬:-
Heatpal Avis (ATTENTION!) Meilleur chauffage Portable en France
===================== Heatpal Avis (ATTENTION!) Meilleur chauffage Portable en France Heatpal Avis: Les températures extrêmes ont augmenté en raison du réchauffement climatique, rendant le chauffage des pièces nécessaire dans les régions froides. Une autre façon de rester au chaud et à l'aise dans la maison en hiver consiste à utiliser des radiateurs. Il existe actuellement plusieurs types, modèles et choix disponibles, ce qui rend difficile la sélection du meilleur appareil de chauffage. Les
Derila Oreiller Avis France: Acheter 50% De Réduction
Derila Oreiller Avis: De nos jours, dormir suffisamment est presque impossible en raison de nos modes de vie trépidants. La plupart du temps, obtenir une nuit de sommeil réparatrice dépend d'avoir les articles de literie appropriés. La recherche a prouvé que vos oreillers et votre matelas peuvent affecter votre sommeil. Cependant, les matelas et oreillers traditionnels ne sont pas adaptés à cette fin. Il provoque des maux de tête et
Diaetoxile Avis France Pharmacie, Négatif, Ou Le Trouver, Forum
Le Diaetoxile Avis, comme vous le savez peut-être maintenant, est une pilule amaigrissante fabriquée à partir d'ingrédients naturels qui ont subi les tests et les recherches nécessaires pour prouver son efficacité. Diaetoxile Avis: Contrairement à la plupart des fabricants de pilules Diaetoxile Avss, les fabricants ne promettent pas d'allégations irréalistes, mais ont fourni des preuves scientifiquement acceptables du fonctionnement du contenu de cette pilule. Cliquez Ici Pour Obtenir Diatoxile Sur Le Site
Diaetoxil Avis France (FR) 50 % De Réduction + Livraison Gratuite
Diaetoxil Avis France: L'obésité est un risque majeur pour la santé qui touche presque tout le monde à un moment donné de sa vie. L'approche typique de la perte de poids consiste à manger moins et à bouger plus, ce qui nécessite de suivre un certain régime et de commencer à faire de l'exercice. Bien que cette formule fonctionne dans la majorité des situations, elle peut n'avoir aucun impact sur
Annabiol CBD Oil en Pharmacie - Prix et Avis Consommateur!
De nos jours, l'anxiété et l'anxiété sont devenues une partie typique de la vie. Ainsi que de nombreuses personnes les ont approuvés comme leur vie. Mais l'approbation n'est pas la solution, la traiter est l'option idéale. Il y a quelques années, il n'y avait aucun remède contre la dépression, le stress et l'anxiété, ou moins de repos. Et maintenant, les biologistes ont trouvé une option étonnante pour cela aussi. L'une